Vaughan Nelson Investment Management L.P. raised its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 37.0% in the 1st quarter, Holdings Channel reports. The firm owned 245,217 shares of the semiconductor company’s stock after acquiring an additional 66,219 shares during the period. Synopsys accounts for approximately 1.0% of Vaughan Nelson Investment Management L.P.’s holdings, making the stock its 29th largest position. Vaughan Nelson Investment Management L.P.’s holdings in Synopsys were worth $97,224,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of the business. Victory Capital Management Inc. grew its position in Synopsys by 238.8% in the third quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock valued at $1,393,506,000 after acquiring an additional 1,990,608 shares during the last quarter. Coatue Management LLC acquired a new stake in shares of Synopsys in the 3rd quarter valued at approximately $892,605,000. Capital Research Global Investors grew its holdings in shares of Synopsys by 226.6% during the 3rd quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock valued at $1,245,533,000 after purchasing an additional 1,751,432 shares during the last quarter. Norges Bank bought a new stake in shares of Synopsys during the 4th quarter valued at approximately $730,197,000. Finally, State Street Corp increased its position in Synopsys by 20.6% during the 3rd quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock worth $4,322,273,000 after purchasing an additional 1,493,912 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages recently commented on SNPS. Wells Fargo & Company increased their price objective on shares of Synopsys from $505.00 to $535.00 and gave the company an “equal weight” rating in a research note on Thursday, May 28th. Piper Sandler upped their price target on shares of Synopsys from $430.00 to $450.00 and gave the stock a “neutral” rating in a report on Thursday, May 28th. Morgan Stanley increased their price target on Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a research note on Thursday, May 28th. BNP Paribas Exane raised their price objective on Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a report on Thursday, May 28th. Finally, Needham & Company LLC restated a “buy” rating and set a $580.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. Nine equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Synopsys has an average rating of “Hold” and an average price target of $563.81.
Insider Transactions at Synopsys
In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by insiders.
Synopsys Price Performance
Shares of NASDAQ SNPS opened at $455.51 on Monday. The company has a market capitalization of $87.22 billion, a P/E ratio of 105.44, a price-to-earnings-growth ratio of 2.68 and a beta of 1.22. Synopsys, Inc. has a 52-week low of $376.18 and a 52-week high of $651.73. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The company’s 50 day moving average price is $479.14 and its 200-day moving average price is $462.21.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. The company had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. Synopsys’s revenue for the quarter was up 41.9% compared to the same quarter last year. During the same period in the prior year, the company posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current year.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
